Skip to content

ADMA Biologics ADMA Deferred taxes

Deferred taxes at other companies

Zymeworks logo
ZymeworksZYME
$236.25K+36.8%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$18.84M-12.2%
Haemonetics logo
HaemoneticsHAE
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.02B-54.5%

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's deferred taxes?
ADMA Biologics (ADMA) reported deferred taxes of $3.29M in Q1 2026.
How has ADMA Biologics's deferred taxes changed year-over-year?
ADMA Biologics's deferred taxes decreased by 3.9% year-over-year, from $3.43M to $3.29M.
What does deferred taxes mean?
The aggregate net change in deferred tax assets and liabilities for the period, representing the tax effects of temporary differences that will reverse in future periods. It is a key indicator of the timing differences between book income and taxable income.